Fundraising FoxFinchley Healthcare Ventures
Corporate VCMontreal · Seed–Late Stage · 16 people tracked
Find your way into Finchley Healthcare Ventures
Each arrow is one introduction. Sign up to fill in the first one.
Ask Daniel Parera to introduce you to Hubert Birner
You →Daniel · together at Leon Nanodrugs →Hubert
Ask Jamie Chen to introduce you to Dominic Caron
You →Jamie · together at Pharmascience →Dominic
Ask Sam Okafor to introduce you to Pierre Beauparlant
You →Sam · together at Sanderling Ventures →Pierre
- Camille Couture106 people can intro you
- Tarık Dutkuner78 people can intro you
- Tarık Dutkuner7 people can intro you
Sign up to find every way you can get introduced to Finchley Healthcare Ventures
- Your email: who you already know at Finchley Healthcare Ventures, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Finchley Healthcare Ventures team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
The firm backs companies developing innovative, transformative prescription medicines aimed at addressing diseases not adequately served by current therapies. It is interested in a broad range of modalities, from small molecules and antibodies to breakthrough technologies such as nanotechnologies. Investment targets span companies approaching their first clinical trial through to those further along in development, with the goal of demonstrating proof of concept in humans. Beyond capital, the firm offers access to a network of professionals in medicine, pharmaceutical R&D, manufacturing, and commercialization to support product optimization and development. It also invests in life sciences venture funds and operates without geographic restriction.
Source: firm website, verified Sep 26, 2026.
Team · 16 people
from the firm's website & curated & public directories
What they invest in
from 6 of 6 portfolio companiesBiotech ×6Healthtech ×4Deep Tech ×3AI & Machine Learning ×2Medical Devices ×2
HQs:United States×4
Investments · 6 tracked
founders shown can be your intro path
AbbVie is a biopharmaceutical company that discovers and delivers medicines for immune-mediated diseases and other therapeutic areas globally.
BiotechHealthtechMedical DevicesSan Diego, US
Adrian Bot(Executive Officer)Laura Shawver(Executive Officer, Director)inRamin Farzaneh-Far(Executive Officer)inJustin Thacker(Executive Officer)Karen Smith(Director)Fabio Pucci(Director)
Co-investorsPfizer Venture InvestmentsRA CapitalSofinnova VenturesVida VenturesForbion
Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US
Max Mumbach(Founding Scientist, Target Discovery)inJeffrey Verboon(Founding Scientist, Computational Biology)inAnsu Satpathy(Founder)Kevin Parker, PhD(Chief Executive Officer, Board Director; co-founder)Ansuman Satpathy, MD, PhD(Co-founder; Board Director)Howard Chang(Co-founder)in
Co-investors8VCAndreessen HorowitzArtis VenturesGlobal BioAccess FundHAWKTAILPfizer Venture Investments+7 more
Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.
AI & Machine LearningBiotech
Pierre Raboisson(Chief Executive Officer Chief Scientific Officer Co-founder)inMarie De Vulder(Chief Legal Officer Co-founder)inGuy Peeters(Chief Financial Officer Co-founder)inJohn-Paul Gallivan(Head of Development Co-founder)inFabrice Kolb(Head of Immunology Co-founder)inPieter Peeters(Operating & Technology Officer Co-founder)in
Co-investorsLongwood FundLuma GroupSofinnova VenturesBAM ElevateForbionNovo Holdings+1 more
Quanta is a biotech company developing orally bioavailable, CNS-penetrant small-molecule KRAS inhibitors targeting RAS-driven cancers such as pancreatic, colorectal, lung, and endometrial cancers.
BiotechDeep TechHealthtechSouth San Francisco, US
Cameron Pitt(Executive Officer, Director)inDerek Metzger(Executive Officer)
BoardMaha Katabi(Director)inPerry Nisen(Executive Officer, Director)inMaria Fardis(Director)inRajul Jain(Director)in
Co-investorsLongitude CapitalSofinnova VenturesVida VenturesBiotechnology Value FundFrazier Life Sciences
Reverb Therapeutics develops immunotherapies built on its Amplify•R platform, which modulates the body's natural immune system using targeted molecules such as IL-15-directed compounds.
BiotechHealthtech
Co-investorsAmplitude Venture CapitalInBC Investment Corp.Thin Air LabsKdT Ventures
TRIANA Biomedicines is a venture-backed biopharmaceutical company developing small-molecule "molecular glue" therapeutics that induce protein:protein interactions to degrade or alter disease-causing target proteins, with an initial focus on targeted protein degradation for cancer.
BiotechDeep TechHealthtechLexington, US
Patrick Trojer(President & Chief Executive Officer)in
Co-investorsAscenta CapitalAtlas VentureLightspeed Venture PartnersRA CapitalBessemer Venture PartnersPfizer Ventures+3 more
Portfolio news
latest coverage across their companiesCartography Biosciences · finsmes.com · May 7, 2026
Coultreon · coultreon.com · Apr 28, 2026
Frequently asked questions
- How many investments has Finchley Healthcare Ventures made?
- Finchley Healthcare Ventures has 6 tracked investments, including 1 dated in the last 24 months.
- What stage does Finchley Healthcare Ventures invest at?
- Finchley Healthcare Ventures invests at the Seed, Series A, Series B, Late Stage stages.
- What sectors does Finchley Healthcare Ventures focus on?
- Finchley Healthcare Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Finchley Healthcare Ventures located?
- Finchley Healthcare Ventures is headquartered in Montreal, CA.
- Who does Finchley Healthcare Ventures co-invest with?
- Finchley Healthcare Ventures most often shares deals with Pfizer Venture Investments, Sofinnova Ventures, RA Capital, among 19 tracked co-investors.
Similar investors
Investinor AS is a Norwegian investment company that partners with founders, entrepreneurs and other investors to help selected promising companies become world-leading.
RiverVest Venture Partners is a life sciences venture capital firm that invests in biotechnology and medical companies, working with entrepreneurs to advance therapeutic and medical innovations.
Pitango is an Israel-based venture capital firm that has backed founders across technology sectors for decades, offering portfolio companies access to a broad network of customers, partners, and leaders.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
OCV Partners is a Los Angeles-based venture capital firm founded by former operators that backs companies with differentiated technologies across technology and healthcare markets.